Blog
Thank you for contacting us; we’ll be in touch shortly.
Top 30 Insights from Top Pharma, Sagent, Patheon & McKesson
Continued insights from the speakers at our DSCSA Serialization Workshop: Pfizer, Sagent, Patheon and McKesson.
China Q&A: Preparing for New Reporting, Data, and Encoding Requirements
Learn how China’s National Medical Products Administration (NMPA) new reporting requirements and serialization options will affect pharmaceutical…
Navigating DSCSA: Choosing a Compliance Approach for Dispensers
Review the different approaches healthcare organizations can take to achieve DSCSA compliance.
Preparing for Russia Compliance: 6 Critical Considerations
Companies that sell product into Russia need to focus on six critical considerations, and understand how Russia challenges differ from those of FMD…
Altran Q&A: Spain’s Small Pharmas Face Big Serialization Challenges for EU FMD
Understand the challenges small pharmas face as serialization approaches, and how industry expert Altran helps solve them.
Russia Regulatory Updates
View a compilation of the most recent track and trace regulations for the healthcare supply chain in Russia. Get insights into compliance updates.
What are the Language Requirements for EU FMD Safety Features?
Discover what language the new unique identifier needs to be in on your medicine packs, depending on which European market you ship to.
Clinical-Stage Pharmas: What Do You Need to Know About Serialization?
See why clinical-stage pharma companies must learn basic DSCSA serialization requirements—or risk years of work and millions of dollars.
Are Your Products China Ready? Three Key Decisions for Multinational Pharma Companies
China's drug administration law and serialization framework for medicines could affect your China product packaging strategy. Learn how today.
How Much Will Serialization Really Cost?
Get insights into how much serialization will really cost your company. Proven serialization solution providers can help identify additional costs.
EU FMD: The Risks of Product Stockpiling
Stockpiling product to delay EU FMD compliance is a temporary approach that offers no long-term value—and carries significant risks.
To Aggregate or Not: 5 Deciding Factors
Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.